13 -

13 - Eatock MM, Tebbutt NC, Bampton CL et al. Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013;24(3):710-8 [link]